HomeNDC LookupRxCUI directory › RxCUI 2048025

0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syringe [Fulphila] — RxCUI 2048025

RxNorm drug concept · Semantic branded drug
RxCUI 2048025 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2048025
Official name0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syringe [Fulphila]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.6 ML Fulphila 10 MG/ML Prefilled Syringe; Fulphila 6 MG in 0.6 ML Prefilled Syringe; Fulphila 6 MG per 0.6 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)16,327 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegfilgrastim Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chemotherapy works by targeting fast-growing cells — but that includes the cells in your bone marrow that make white blood cells. When white blood cell counts drop too low, your bo...
  • Why do I need this injection if I'm already getting chemotherapy?
  • It's given as a shot just under the skin — subcutaneously. Depending on the product and your situation, you might receive it via a manual prefilled syringe, or with the Neulasta on...
  • The most common side effects are bone pain and aching in your arms and legs — your bones are working harder to produce white blood cells, so some discomfort is normal. But call you...
📖 Read our full Pegfilgrastim Injection guide →

🕸️ Concept Web — How 0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syringe [Fulphila] RxCUI 2048025

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pegfilgrastim 338036
    • Pegfilgrastim-jmdb 2048018
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fulphila 2048021
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pegfilgrastim Prefilled Syringe 727538
    • Pegfilgrastim-jmdb Prefilled Syringe 2649411
    • Pegfilgrastim Injectable Product 1161380
    • Pegfilgrastim-jmdb Injectable Product 2660987
    • Pegfilgrastim Prefilled Syringe [Fulphila] 2048023
    • Pegfilgrastim-jmdb Prefilled Syringe [Fulphila] 2654943
    • Fulphila Injectable Product 2048024
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syringe SCD · 2048020
  • Pegfilgrastim-jmdb 10 MG/ML SCDC · 2048019
  • Pegfilgrastim Prefilled Syringe SCDF · 727538
  • Pegfilgrastim-jmdb Prefilled Syringe SCDFP · 2649411
  • Pegfilgrastim Injectable Product SCDG · 1161380
  • Pegfilgrastim-jmdb Injectable Product SCDGP · 2660987

Brand-Name Concepts

  • Pegfilgrastim-jmdb 10 MG/ML [Fulphila] SBDC · 2048022
  • Pegfilgrastim Prefilled Syringe [Fulphila] SBDF · 2048023
  • Pegfilgrastim-jmdb Prefilled Syringe [Fulphila] SBDFP · 2654943
  • Fulphila Injectable Product SBDG · 2048024
  • Fulphila BN · 2048021

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2048025 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83257-0005-41 1 SYRINGE in 1 CARTON (83257-005-41) / .6 mL in 1 SYRINGE Fulphila Biocon Biologics Inc. 2023-10-01
Observed labelers: Biocon Biologics Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$3,185.9400
Range $3,185.9400–$3,185.9400 · middle 50% $3,185.9400–$3,185.9400 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5108 Injection, fulphila 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.